Büchi Labortechnik

Second Annual: TOXICOGENOMICS IN DRUG SAFETY ASSESSMENT, London, UK

Tuesday, December 04, 2007 - Wednesday, December 05, 2007

Print Email to a friend

Danubius Hotel Regents Park, London

Assess the real potential of toxicogenomics by joining an array of regulatory, academic and industry experts as they outline the achievements and look forward to future discoveries:


  • Validation and submission of Toxicogenomics data – A regulatory consideration
  • Toxicogenomics mechanism-based risk assessment
  • Incorporation of liver Toxicogenomics into early pre-clinical studies
  • Assessing the use of Toxicogenomics for the early identification of biomarkers
  • Recent and future applications of DNA microarray technologies in toxicology

Expert Speakers include industry experts from Abbot, Merck Serono, GlaxoSmithKline, Johnson & Johnson and Nestle PLUS Weida Tong, Director, FDA’s National Center for Toxicological Research and - Jeurgen Borlak, Director, Fraunhofer Institute of Toxicology and Experimental Medicine and Medical School of Hanover, Germany

Quote CQ4065TN to Save £200
Email: registrations@informa-ls.com
Tel: +44 (0) 20 7017

    Further Information: http://www.iir-events.com/IIR-Conf/page.aspx?id=9637